Vext Science Achieves Record Q1 Revenue and Expands Ohio Footprint

Vext Science ( (TSE:VEXT) ) has issued an update.

Vext Science reported a record Q1 performance with $11.6 million in revenue, a 38% increase from Q1 2024, driven by growth in Ohio. The company’s operating cash flow reached $3.1 million, matching its entire 2024 cash generation, highlighting the success of its retail strategy. Vext doubled its Ohio retail footprint by acquiring two dispensaries, enhancing its market presence. The company is focused on expanding in Ohio, reducing debt, and delivering sustainable returns for shareholders.

The most recent analyst rating on (TSE:VEXT) stock is a Buy with a C$0.60 price target. To see the full list of analyst forecasts on Vext Science stock, see the TSE:VEXT Stock Forecast page.

Spark’s Take on TSE:VEXT Stock

According to Spark, TipRanks’ AI Analyst, TSE:VEXT is a Neutral.

Vext Science’s overall score reflects significant challenges in financial performance, with profitability and cash flow issues weighing heavily. While the company shows potential with strategic expansions in Ohio and positive earnings call highlights, weak technical indicators and poor valuation metrics limit the stock’s attractiveness. Continued focus on operational efficiency and cash flow generation will be key to improving its financial health.

To see Spark’s full report on TSE:VEXT stock, click here.

More about Vext Science

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. The company focuses on a retail-first approach, particularly in Ohio, leveraging a capital-light build-out model to open profitable new stores quickly. Vext aims to serve its own retail shelves rather than the wholesale market, ensuring consistent cash flow and supporting its growth strategy.

Average Trading Volume: 111,235

Technical Sentiment Signal: Sell

Current Market Cap: C$27.23M

Learn more about VEXT stock on TipRanks’ Stock Analysis page.